Stockreport

Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant

Titan Pharmaceuticals, Inc.  (TTNP) 
NASDAQ:AMEX Investor Relations: ir.titanpharm.com